U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07706764) titled 'A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism' on June 23.
Brief Summary: This trial will enroll adolescents between ages of >=12 and <18 years with clinically diagnosed hypoparathyroidism . The purpose of the study is to see how well treatment with once-daily palopegteriparatide works and how safe it is. At least 12 participants will receive palopegteriparatide for 234 weeks. This trial will be conducted in Europe.
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
Hypoparathyroidism
Intervention:
COMBINATION_PRODUCT: Palopegteriparatide
Subcutane...